RxDoctor Payments Data

Scott Booker, DO

Family Medicine · Garden City, KSNPI 1447216411

Payments from drug & device makers

$298in general payments, 2019–2025

Across 11 payments — averaging $27.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dexcom, Inc.$73
  • Mylan Specialty L.p.$71
  • Medtronic$64
  • Novo Nordisk$31
  • Sanofi-aventis U.S. LLC$23
  • Kowa Pharmaceuticals America, Inc.$13
  • plus $23 from 2 others

What the payments were for

  • Food & beverage$298100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$298 in reported general payments places this provider in the 40th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$143,687
Medicare patients
527
Services billed
1,747

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide191$185,709
XareltoRivaroxaban148$88,740
EliquisApixaban132$86,409
Trelegy ElliptaFluticasone/Umeclidin/Vilanter39$31,218
MyrbetriqMirabegron39$17,629
JardianceEmpagliflozin37$17,579
JanuviaSitagliptin Phosphate23$16,289
MounjaroTirzepatide14$14,792
Repatha SureclickEvolocumab26$14,108
Novolog FlexpenInsulin Aspart26$13,911
OxycontinOxycodone Hcl15$12,254
FarxigaDapagliflozin Propanediol15$11,944
InvokametCanagliflozin/Metformin Hcl18$10,515
Levothyroxine Sodium1,105$9,935
Repatha SyringeEvolocumab16$9,894

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$31$185,709191 claims
PfizerEliquis, Abrysvo$12$92,496152 claims
Lilly USA, LLCMounjaro$11$14,79214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Garden City

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →